HBM HOLDINGS-B(02142),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02142 HBM HOLDINGS-B

Not Yet Opened 07-23 16:08:06

12.350

-0.250

-1.98%

High12.850	Low12.330	Vol1.44M
Open12.600	D1 Closing12.600	Amplitude4.13%
Mkt Cap10.72B	Tradable Cap10.72B	Total Shares868.00M
T/O18.07M	T/O Rate0.17%	Tradable Shares868.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02142","market":"HK","secType":"STK","nameCN":"HBM HOLDINGS-B","latestPrice":12.35,"timestamp":1784794086003,"preClose":12.6,"halted":0,"volume":1444347,"delay":0,"changeRate":-0.01984126984126984,"floatShares":868000000,"shares":868000000,"eps":0.8624948054290127,"marketStatus":"Not Yet Opened","change":-0.25,"latestTime":"07-23 16:08:06","open":12.6,"high":12.85,"low":12.33,"amount":18066646,"amplitude":0.04127,"askPrice":12.35,"askSize":39000,"bidPrice":12.34,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.8624869645671451,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784856600000},"marketStatusCode":0,"adr":0,"listingDate":1607529600000,"exchange":"SEHK","adjPreClose":12.6,"openAndCloseTimeList":[[1784770200000,1784779200000],[1784782800000,1784793600000]],"volumeRatio":0.4116590193722069,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02142","defaultTab":"news","newsList":[{"id":"2653922277","title":"Nona Biosciences Enters Research Collaboration with the Medical University of Vienna to Advance Fully Human Antibody Development for Infectious Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2653922277","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653922277?lang=en_us&edition=fundamental","pubTime":"2026-07-23 08:55","pubTimestamp":1784768151,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nTUA969V9V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","BK1583","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653627641","title":"Is HBM Holdings (SEHK:2142) Fully Valued After Its Asthma IND Approval?","url":"https://stock-news.laohu8.com/highlight/detail?id=2653627641","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653627641?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:16","pubTimestamp":1784629000,"startTime":"0","endTime":"0","summary":"HBM Holdings (SEHK:2142) is in focus after China’s National Medical Products Administration approved the Investigational New Drug application for HBM7575/SKB575, a long-acting bispecific antibody candidate for asthma co-developed with Kelun-Biotech.\nSee our latest analysis for HBM Holdings.\nThe IND approval appears to have reinforced interest in HBM Holdings, with the HK$11.96 share price supported by a 9.72% 1 month share price return and a very large 3 year total shareholder return, even...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/is-hbm-holdings-sehk2142-fully-valued-after-its-asthma-ind-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/is-hbm-holdings-sehk2142-fully-valued-after-its-asthma-ind-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK1161","HBM","MIC","DRMY","MUZ","HBMX","DCF","BK1574","BK1583","RAM","MULL","DRAM","IND","DRAL","MUYY","BK4168","DISK","DRMP","02142","MUD","MUU","COPP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651419178","title":"HBM Holdings's Asthma Drug Candidate Secures China's Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2651419178","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651419178?lang=en_us&edition=fundamental","pubTime":"2026-07-16 14:40","pubTimestamp":1784184006,"startTime":"0","endTime":"0","summary":"HBM Holdings (HKG:2142) investigational new drug application for HBM7575, a long-acting bispecific antibody for asthma treatment, has been approved by China's National Medical Products Administration.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0196878994.USD","MULL","02142","06990","BK1574","DRAM","MUD","RAM","MUU","BK1583","BK4588","DRAL","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124796546","title":"HBM HOLDINGS-B Receives Regulatory Clearance for Asthma Drug Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1124796546","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124796546?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:06","pubTimestamp":1784109988,"startTime":"0","endTime":"0","summary":"The China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for HBM7575, also known as SKB575.This long-acting bispecific antibody targets...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02142","BK1583","BMED","IBBQ","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451920","title":"China NMPA Clears Kelun-biotech, Harbour Biomed Asthma IND for Skb575/hbm7575","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451920","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451920?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:02","pubTimestamp":1784109748,"startTime":"0","endTime":"0","summary":"China NMPA clears Kelun-Biotech, Harbour BioMed asthma IND for SKB575/HBM7575China’s NMPA cleared an IND for SKB575/HBM7575, a long-acting bispecific antibody for asthma.The drug is co-developed by Ke","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL9mBrfs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934453819.USD","LU0196878994.USD","LU1064130708.USD","06990","02142","BK1574","LU1064131003.USD","BK0239","LU2148510915.USD","BK1161","BK0060","BK1583","LU1979443071.USD","002422"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451667","title":"Hbm Holdings - Hbm7575 Co-developed by Harbour Biomed and Kelun-biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451667?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:00","pubTimestamp":1784109651,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0F9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","06990","BK1161","02142","BK1583","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451610","title":"Hbm Holdings - Nmpa Approves Ind Application for Hbm7575 for Asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451610?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:00","pubTimestamp":1784109651,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0F9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1583","BK1161","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113050886","title":"HBM Holdings Monthly Return: Issued Shares Edge Up 0.08% on Option Exercises; Public Float Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=1113050886","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113050886?lang=en_us&edition=fundamental","pubTime":"2026-07-07 17:06","pubTimestamp":1783415166,"startTime":"0","endTime":"0","summary":"HBM Holdings Limited released its Monthly Return for the period ended 30 June 2026, detailing marginal changes in share capital driven by option exercises. Key Takeaways   • Authorised share capital...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649691134","title":"HBM Holdings (SEHK:2142) Teams Up With Lonza, Is The Stock Already Fully Valued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2649691134","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649691134?lang=en_us&edition=fundamental","pubTime":"2026-07-04 22:32","pubTimestamp":1783175554,"startTime":"0","endTime":"0","summary":"Nona Biosciences, part of HBM Holdings (SEHK:2142), has entered a collaboration with Lonza to co-develop single domain antibody blood brain barrier crossing technology for central nervous system diseases, drawing fresh attention to HBM Holdings stock.\nSee our latest analysis for HBM Holdings.\nThe Lonza partnership has arrived at a time when HBM Holdings’ share price has gained 5.47% in the last day and 13.12% over the past week, yet remains down 21.35% over 90 days. Meanwhile, the 1 year...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-teams-up-with-lonza-is-the-stock-alrea","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2142/hbm-holdings-shares/news/hbm-holdings-sehk2142-teams-up-with-lonza-is-the-stock-alrea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MUD","COPP","DRAL","BK1574","02142","BK1161","HBM","MULL","MUU","BK1583","RAM","BK4588","BK4168","DCF","DRAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648522004","title":"Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-class Single-domain Antibody-based Bbb-crossing Technology for CNS Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2648522004","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648522004?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:05","pubTimestamp":1782950754,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUA6LHHSR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1583","BK1161","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647374356","title":"Shanghai Court Dismisses HBM Subsidiary's Patent Infringement Claim Against Biocytogen","url":"https://stock-news.laohu8.com/highlight/detail?id=2647374356","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647374356?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:46","pubTimestamp":1782737188,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals (Beijing) (HKG:2315) scored a legal win in China after a court dismissed a claim made by HBM (HKG:2142) subsidiary Harbour Antibodies.Specifically, the Shanghai Intellectual","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02315","DRAM","BK1161","BK1574","BK4588","BK1583","02142","RAM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647916344","title":"Harbour Biomed Appoints Lloyd Klickstein Scientific Advisor for Immunology","url":"https://stock-news.laohu8.com/highlight/detail?id=2647916344","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647916344?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:28","pubTimestamp":1782696496,"startTime":"0","endTime":"0","summary":"Harbour BioMed appoints Lloyd Klickstein scientific advisor for immunologyHBM Holdings appointed Lloyd Klickstein as scientific advisor for immunology on June 28, 2026.Klickstein is CEO of Koslapp The","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDLbz98kH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK1583","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115452403","title":"HBM Holdings Annual Meeting: All Eight Resolutions Secure Strong Shareholder Support","url":"https://stock-news.laohu8.com/highlight/detail?id=1115452403","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115452403?lang=en_us&edition=fundamental","pubTime":"2026-06-25 22:45","pubTimestamp":1782398700,"startTime":"0","endTime":"0","summary":"HBM Holdings Limited reported that every agenda item at its 25 June 2026 Annual General Meeting passed with wide margins, confirming board stability and refreshed corporate mandates. Key voting...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144425345","title":"HBM HOLDINGS-B Shares Surge on AI Drug Discovery Venture Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=1144425345","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144425345?lang=en_us&edition=fundamental","pubTime":"2026-06-17 10:48","pubTimestamp":1781664505,"startTime":"0","endTime":"0","summary":"Shares of HBM HOLDINGS-B (02142) have risen more than 5%. At the time of writing, the stock is up 5.34% to HK$10.66, with a turnover of HK$11.05 million. The increase follows a recent company...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1574","BK4585","AIPO","BK1161","AGIX","02142","ARTY","BK1583","CHAT","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171995009","title":"HBM Holdings and Baidu's Biotech Arm Forge AI Drug Discovery Alliance, Launching MegaStream TechBio","url":"https://stock-news.laohu8.com/highlight/detail?id=1171995009","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171995009?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:20","pubTimestamp":1781526037,"startTime":"0","endTime":"0","summary":"HBM Holdings-B (HKEX: 02142) has announced a comprehensive, long-term strategic partnership with Baidu's biotech subsidiary, Baitu Shengke. The collaboration will focus on AI-driven discovery and...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02142","ARTY","AGIX","BK1574","CHAT","BK1583","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643203523","title":"HBM Holdings partners with BioMap to co-found AI drug R&D venture MegaStream TechBio","url":"https://stock-news.laohu8.com/highlight/detail?id=2643203523","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643203523?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:08","pubTimestamp":1781525286,"startTime":"0","endTime":"0","summary":"HBM Holdings launched a strategic partnership with BioMap to co-build AI drug developer MegaStream TechBio for global markets.MegaStream will combine proprietary datasets, bespoke foundation models, integrated discovery platforms to advance complex biologic pipelines.HBM will contribute its fully human antibody platform, target biology capabilities, clinical development experience.BioMap will provide AI technology, model engineering support, automated R&D capabilities to accelerate pipeline progress.Founders expect upfront payments, milestone payments, profit-sharing from MegaStream programs; initial pipeline to include prior joint AI projects.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HBM Holdings Ltd. published the original cont","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDL7FGbB0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1583","02142","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643566203","title":"Hbm - Co and Biomap to Jointly Initiate Megastream Techbio","url":"https://stock-news.laohu8.com/highlight/detail?id=2643566203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643566203?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:07","pubTimestamp":1781525220,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nFWN42N01Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","BK1574","BK1161","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643033702","title":"Hbm - Co and Biomap Enter Global Strategic Partnership for AI-Driven Biologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2643033702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643033702?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:07","pubTimestamp":1781525220,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nFWN42N01Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1583","BK1574","02142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112124731","title":"HBM Holdings-B Prevails in Patent Infringement Case Against Amgen, Awarded Approximately $20.2 Million with Potential for Triple Damages","url":"https://stock-news.laohu8.com/highlight/detail?id=1112124731","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112124731?lang=en_us&edition=fundamental","pubTime":"2026-06-15 08:47","pubTimestamp":1781484475,"startTime":"0","endTime":"0","summary":"In a recent legal development, HBM Holdings-B (ASX: 02142) has announced a favorable jury verdict in a patent infringement lawsuit. The jury in the U.S. District Court for the District of Delaware...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","02142","AMGN","BK1583","LU0122379950.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU0889565916.HKD","BK1161","LU2468319806.SGD","LU0109394709.USD","BK4585","BK1574","BK4533","IE0002141913.USD","IE00BFTCPJ56.SGD","LU1571399168.USD","LU1023059063.AUD","BK4139","LU2242646821.SGD","BK4588","BK4534","LU2089984988.USD","LU0868494617.USD","LU1983299246.USD","BK4566","LU1061106388.HKD","IE00BJT1NW94.SGD","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU0058720904.USD","IE0009355771.USD","LU2242652126.USD","BK4581","LU2112291526.USD","LU0289739699.SGD","BK4599","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643280482","title":"Harbour Biomed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape","url":"https://stock-news.laohu8.com/highlight/detail?id=2643280482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643280482?lang=en_us&edition=fundamental","pubTime":"2026-06-15 08:02","pubTimestamp":1781481734,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA3HC08Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1574","BK1583","02142"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0152},{"period":"1month","weight":0.1773},{"period":"3month","weight":-0.1179},{"period":"6month","weight":0.0016},{"period":"1year","weight":0.4327},{"period":"ytd","weight":0.0156}],"compareEarnings":[{"period":"1week","weight":0.0081},{"period":"1month","weight":0.0803},{"period":"3month","weight":-0.0295},{"period":"6month","weight":-0.0575},{"period":"1year","weight":-0.0128},{"period":"ytd","weight":-0.0164}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Hbm Holdings Ltd is an investment holding company primarily engaged in the business of developing innovative therapeutics in the fields of immuno-oncology and immunology diseases. The Company’s products primarily include BATOCLIMAB (HBM9161), HBM9378, HBM7020, TCE Program, PORUSTOBART (HBM4003), HBM7022 and others. The products are primarily used to treat generalized myasthenia gravis (gMG), chronic obstructive pulmonary disease (COPD), asthma, autoimmune diseases, melanoma, colorectal carcinoma (CRC) and solid tumors. The Company provides next-generation antibody and biotherapeutic solutions through proprietary antibody technology platforms including Harbour Mice, HBICE, HBICA and single B cell cloning platform.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.083377},{"month":2,"riseRate":0.333333,"avgChangeRate":0.000026},{"month":3,"riseRate":0.5,"avgChangeRate":0.051559},{"month":4,"riseRate":0.333333,"avgChangeRate":0.009952},{"month":5,"riseRate":0.5,"avgChangeRate":0.016802},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.072876},{"month":7,"riseRate":0.5,"avgChangeRate":0.055789},{"month":8,"riseRate":0.2,"avgChangeRate":0.005624},{"month":9,"riseRate":0.4,"avgChangeRate":-0.065735},{"month":10,"riseRate":0,"avgChangeRate":-0.180686},{"month":11,"riseRate":0.8,"avgChangeRate":0.25789},{"month":12,"riseRate":0.6,"avgChangeRate":0.266929}],"exchange":"SEHK","name":"HBM HOLDINGS-B","nameEN":"HBM HOLDINGS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"HBM HOLDINGS-B(02142),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest HBM HOLDINGS-B(02142) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"HBM HOLDINGS-B,02142,HBM HOLDINGS-B股票,HBM HOLDINGS-B股票老虎,HBM HOLDINGS-B股票老虎国际,HBM HOLDINGS-B行情,HBM HOLDINGS-B股票行情,HBM HOLDINGS-B股价,HBM HOLDINGS-B股市,HBM HOLDINGS-B股票价格,HBM HOLDINGS-B股票交易,HBM HOLDINGS-B股票购买,HBM HOLDINGS-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"HBM HOLDINGS-B(02142),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest HBM HOLDINGS-B(02142) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}